|
 |
Gynazole 1This page contains recent news articles, when available, and an overview of Gynazole 1 but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.ST. LOUIS, Sept. 21 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company announced today that it has signed a licensing agreement with Theramex SpA for the ... $4.95 - PR Newswire - ECNext … Company Announces Approvals for its Gynazole-1(R) in 15 Countries. - Aug 17, 2005 ST. LOUIS, Aug. 17 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company announced today that it has received notification of approvals to market ... $4.95 - PR Newswire - ECNext Press Release: KV Pharmaceutical Company Licenses Two Women's … - Jan 10, 2005 KV Pharmaceutical Company Licenses Two Women's Health Products for Marketing in Mexico. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research KV Pharmaceutical Reports Record Revenues for Fiscal 2006 Third … - Feb 7, 2006 ST. LOUIS, Feb. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa; KVb) today reported results for the third quarter and nine months of ... RedOrbit International Approvals: Adderall XR, Gynazole-1, Leuplin SR - Aug 29, 2005 Aug. 29, 2005 — Health Canada has reinstated marketing authorization for a once-daily, extended-release formulation of a single-entity amphetamine product ... Medscape Press Release: KV Signs Expanded Worldwide Partnership With Acrux, … - Aug 12, 2008 KV Signs Expanded Worldwide Partnership With Acrux, Including the Development of Six New Branded Products. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research KV Pharmaceutical Company Licenses Two Women's Health Products for … - Jan 10, 2005 ST. LOUIS, Jan. 10 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company announced today that it has entered into agreements with Representaciones E ... RedOrbit KV Signs Licensing Agreement for the Marketing of Clindesse(TM) in 18... - Dec 1, 2005 ST. LOUIS, Dec. 1 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company announced today that it has concluded a long-term licensing agreement with Gedeon ... RedOrbit KV expects October due date for preterm labor drug approval - Aug 29, 2008 KV Pharmaceutical Co. is awaiting an October deadline for federal approval of a drug anticipated to boost company revenue while combating a national health ... Bizjournals.com … Announces First Asian Approval For Gynazole-1(R). - PR Newswire | ... - Aug 25, 2005 ST. LOUIS, Aug. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company announced today that its licensee, Pan Malayan, has received approval to market KV's ... Pay-Per-View - PR Newswire - HighBeam Research Article: Time to stop whinging about portfolios.(LETTERS)(Brief... - Mar 1, 2007 Time to stop whinging about portfolios.(LETTERS)(Brief article) ... find Kai Tiaki: Nursing New Zealand articles. As a full-time mother of two under ... Pay-Per-View - Kai Tiaki: Nursing New Zealand - HighBeam Research KV Pharmaceutical Company Reports Record Revenues for Fiscal 2006 … - Nov 9, 2005 ST. LOUIS, Nov. 9 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVA; KVB) today reported strong revenue growth for the second quarter and first ... Free with registration - PR Newswire - AccessMyLibrary.com KV Pharmaceutical Company Reports Fiscal 2006 Results. - Jun 14, 2006 ST. LOUIS, June 14 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company , a fully integrated specialty pharmaceutical company that develops, manufactures, ... Free with registration - PR Newswire - AccessMyLibrary.com KV Pharmaceutical Company Reports Preliminary Unaudited Fiscal 2007 … - May 31, 2007 ST. LOUIS, May 31 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company a fully integrated specialty pharmaceutical Company that develops, manufactures, ... $4.95 - PR Newswire - ECNext KV Pharmaceutical Company Licenses Two Women's Health Products for … - Mar 31, 2005 ST. LOUIS, March 31 /PRNewswire-FirstCall/ -- . KV Pharmaceutical Company announced today that it has entered into an agreement with ISDIN, SA, an affiliate ... Free with registration - PR Newswire - AccessMyLibrary.com KV Pharmaceutical Company Reports Preliminary Record Revenues for … - Nov 6, 2006 ST. LOUIS, Nov. 6 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company today reported preliminary financial results reflecting strong revenue growth for the ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: KV Pharmaceutical Company Announces Acquisition of … - Jan 22, 2008 KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … nitrate 2% Site Release[R] vaginal cream (Gynazole-1[R]) compared... - Jan 1, 2005 Background. It is estimated that as many as 13 million cases of vulvovaginal infection occur in the United States annually, the majority of which are the ... Free with registration - Infectious Diseases in Obstetrics and... - AccessMyLibrary.com KV Pharmaceutical Reports Record Revenues for Fiscal 2005 Third … - Feb 1, 2005 KV Pharmaceutical Company today reported results for the third quarter and nine months of fiscal 2005 ended December 31, 2004. ... $4.95 - PR Newswire - ECNext Press Release: KV Pharmaceutical Signs POA/Vitaflo Scandinavia AB to ... - Sep 19, 2005 KV Pharmaceutical Signs POA/Vitaflo Scandinavia AB to Market Women's Health Products in Five Scandinavian Markets. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: KV Pharmaceutical Company Licenses Two Women's … - Mar 31, 2005 KV Pharmaceutical Company Licenses Two Women's Health Products for Marketing In Spain, Portugal and Andorra; KV Signs Agreement with ISDIN, SA (Esteve/Puig) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: St. Jude Projects 90 Percent Cure Rate for ALL. - PR … - Jan 11, 2006 St. Jude Projects 90 Percent Cure Rate for ALL. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: Work-experience program gives students live vocational... - Jun 10, 2005 Work-experience program gives students live vocational training.(SportsL) ... find The Virginian Pilot articles. Byline: CHRISTY BARRITT BY Christy Barritt ... Pay-Per-View - Virginian-Pilot - HighBeam Research ESPERA CAPTAR MERCADO - Mar 15, 2007 ...(Peru.com: 2007/3/15) De acuerdo a información brindada por OM Perú, laboratorio peruano filial de la suiza OM Pharma, el mercado de antimicóticos local ... Perú.com … Partner in KV's Licensing Network for Gynazole-1(R) and Clinde - Sep 21, 2005 Another Prestigious International Partner in KV's Licensing Network for Gynazole-1(R) and Clindesse(TM). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research KV Pharmaceutical Company Reports Fiscal 2006 First Quarter Results. - Aug 9, 2005 ST. LOUIS, Aug. 9 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company today reported results for the first quarter of fiscal 2006 ended June 30, 2005. ... $4.95 - PR Newswire - ECNext KV Pharmaceutical Signs Second International Licensing Agreement for ... - Mar 9, 2005 KV Pharmaceutical Company announced today that it has concluded an exclusive licensing agreement with Sigma Pharma Ltda., a division of EMS S/A, ... $4.95 - PR Newswire - ECNext Press Release: KV Signs Licensing Agreement for the Marketing of … - Dec 1, 2005 KV Signs Licensing Agreement for the Marketing of Clindesse(TM) in 18 Eastern European Countries. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: PCI suggests changes to background Check Model Act.(Capitol ... - Jan 1, 2005 PCI suggests changes to background Check Model Act.(Capitol Beat) ... find Claims articles. Several key issues remain unresolved in the Criminal History ... Pay-Per-View - Claims - HighBeam Research KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(... - Jan 22, 2008 ST. LOUIS, Jan. 22 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company , a fully integrated specialty pharmaceutical company that develops, manufactures, ... Free with registration - PR Newswire - AccessMyLibrary.com KV pays $150 million for the right to sell drug - Mar 31, 2007 These include PrimaCare prenatal vitamins and Gynazole-1 treatment for yeast infections. "EvaMist is a great strategic fit with our Ther-Rx women's health ... $2.95 - St. Louis Post-Dispatch - NewsBank Branded drug unit drives KV sales growth - Nov 8, 2006 KV Pharmaceutical Co., based in Brentwood, on Monday said strong growth in its branded drug unit drove an overall increase of 13 percent in second-quarter ... $2.95 - St. Louis Post-Dispatch - NewsBank Sexual & Reproductive Health; Vaginal antibacterial, antifungal... - Feb 7, 2005 2005 FEB 7 - (NewsRx.com & NewsRx.net) -- KV Pharmaceutical Company (KVa/KVb) announced that it has entered into agreements with Representaciones E ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones KV Pharma licenses products in Scandinavia - Sep 19, 2005 KV Pharmaceutical Co. will license two of its women's health products to Vitaflo Scandinavia AB to be marketed in five Scandinavian countries, ... St. Louis Business Journal Press Release: 3united Opens Subsidiaries in Russia, Croatia and the ... - Apr 4, 2005 3united Opens Subsidiaries in Russia, Croatia and the Czech Republic; By Investing in New Locations, the Vienna-based 3united AG is Consolidating its Market ... Pay-Per-View - PR Newswire - HighBeam Research KV Pharmaceutical Reports Preliminary Record Revenues for Fiscal 2007... - Feb 7, 2007 ST. LOUIS, Feb. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company today reported preliminary financial results for the third quarter and first ... Free with registration - PR Newswire - AccessMyLibrary.com KV Pharma licenses two women's products for Mexico.(KV … - Jan 17, 2005 USA-based KV Pharmaceutical says that it has entered into agreements with Representaciones E Investigaciones Medicas, SA de CV (RIMSA) for the licensing ... $4.95 - Pharma Marketletter - ECNext Competitors by Product Report - Dec 27, 2008 Healthcare. Biopharmaceuticals. Endocrinology/Metabolism. Pituitary Gland Disorders. Pituitary Hyperthyroidism (TSH-Induced). Thyroid Hormones ... $75.00 - Revere - Alacra Store KV Pharmaceutical Company to Market New Generic Drugs in US Via … - Feb 14, 2006 ST. LOUIS, Feb. 14 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa; KVb) and Gedeon Richter, Ltd. announced today that KV Pharmaceutical ... RedOrbit Article: On the look out for well-priced assets. - Australasian... - Sep 7, 2005 On the look out for well-priced assets. ... find Australasian Business Intelligence articles. Byline: Eli Greenblat Sep 07, 2005 (The Australian Financial ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Business & Finance; KV Pharmaceutical reports preliminary revenue of ... - Dec 4, 2006 2006 DEC 4 - (NewsRx.com) -- KV Pharmaceutical Co. (KVa/KVb) reported preliminary financial results reflecting strong revenue growth for the second quarter ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones United States top 200 generic drugs by retail sales in dollars and... - Mar 6, 2006 United States top 200 generic drugs by retail sales in dollars and percent change for 2005. 5257010 Title: Top 200 generic drugs by retail dollars in 2005. ... $20.00 - Drug Topics - Alacra Store KV Pharmaceutical Announces Launch of Two Strengths of Generic … - Jul 26, 2007 ST. LOUIS, July 26 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVA; KVB) announced today that it has begun shipment of its 100 mg and 200 mg ... $4.95 - PR Newswire - ECNext KV's 4th-qtr 2006 net income increases 16%. - Feb 19, 2007 KV's 4th-qtr 2006 net income increases 16%. The USA's KV Pharmaceutical says that its revenue for the fourth quarter of 2006 increased 16% to $114.5 million ... $9.94 - Pharma Marketletter - Alacra Store KV Pharmaceutical Company Reports Fiscal 2007 First Quarter Results. - Aug 8, 2006 ST. LOUIS, Aug. 8 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company today reported results for the first quarter of fiscal 2007 ended June 30, 2006. ... $4.95 - PR Newswire - ECNext St. Louis Post-Dispatch (MO) - Jan 11, 2005 Delta cuts will mean a reduction in crews New staffing cuts at Delta Air Lines Inc. will mean service changes for passengers on overseas flights, ... $2.95 - St. Louis Post-Dispatch - NewsBank Article: Sigma's flaming Arrow fires 15pc growth. - Australasian... - Mar 20, 2006 Sigma's flaming Arrow fires 15pc growth. ... find Australasian Business Intelligence articles. Byline: Elizabeth Colman Mar 20, 2006 (The Australian - ABIX ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research «Рихтер Гедеон Ð Ñ‚.»: новые партнерÑ?кие Ñ?оглашениÑ? - Dec 12, 2005 «Рихтер Гедеон Ð Ñ‚.» и компаниÑ? «Forest Laboratories Holdings Ltd.» («ФореÑ?Ñ‚ ЛабораториеÑ? ХолдингÑ? Лтд.», СШÐ?) заключили два новых договора о Ñ?отрудничеÑ?тве ... Ð?птека online Press Release: KV Pharmaceutical Company to Market New Generic … - Feb 14, 2006 KV Pharmaceutical Company to Market New Generic Drugs in US Via Exclusive Deal With Gedeon Richter. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research United States top 200 generic drugs by retail sales in dollars for... - Feb 28, 2005 United States top 200 generic drugs by retail sales in dollars for 2004. 4627202 Title: Top generics based on retail dollar. Source: Chain Drug Review, ... $20.00 - Chain Drug Review - Alacra Store Article: Drug edict ruled out as too hasty.(Brief Article) - Australas... - Mar 30, 2005 Drug edict ruled out as too hasty.(Brief Article) ... find Australasian Business Intelligence articles. Mar 29, 2005 (The Australian Financial Review - ABIX ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Terconazole vaginal cream approved.(PRODUCTS) | Article from OB … - Apr 1, 2005 Terconazole vaginal cream approved.(PRODUCTS) ... find OB GYN News articles. Generic terconazole vaginal cream, 0.4% has been approved for the local ... Pay-Per-View - OB GYN News - HighBeam Research KV.A Licenses Two Women's Health Products for Marketing - Mar 31, 2005 KV Pharmaceutical Company (NYSE: KV.A) announced that it has entered into an agreement with ISDIN, SA, an affiliate of Esteve, Spain's 6th largest ... StreetInsider.com - StreetInsider.com (subscription) KV Pharmaceutical Company Reports Fiscal 2005 Results. - Jun 14, 2005 ST. LOUIS, June 14 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company , a fully integrated specialty pharmaceutical company that develops, manufactures and ... $4.95 - PR Newswire - ECNext Article: Sigma says its year is shaping up as forecast. - Australasian... - Sep 7, 2005 Sigma says its year is shaping up as forecast. ... find Australasian Business Intelligence articles. Byline: Julie Medew Sep 07, 2005 (The Sydney Morning ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Article: Sigma posts solid result. - Australasian Business Intelligenc... - Sep 14, 2005 Sigma posts solid result. ... find Australasian Business Intelligence articles. Sep 14, 2005 (Inside Retailing - ABIX via COMTEX) -- Australia's Sigma has ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Article: Sigma, Arrow in $2.2b drug union. - Australasian Business … - Aug 22, 2005 Sigma, Arrow in $2.2b drug union. ... find Australasian Business Intelligence articles. Byline: Rebecca Urban Aug 22, 2005 (The West Australian - ABIX via ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Article: Chemists' discounts rort under attack.(Brief Article) -... - Apr 13, 2005 Chemists' discounts rort under attack.(Brief Article) ... find Australasian Business Intelligence articles. Apr 13, 2005 (The Australian Financial Review ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research KV and Richter Gedeon expand license deal.(Brief Article) - Dec 12, 2005 The USA's KV Pharmaceutical Co has concluded a long-term licensing agreement with Hungarian drug giant Richter Gedeon to market the former's Clindesse ... $4.95 - Pharma Marketletter - ECNext Healthcare & Pharmaceuticals: Hungary - Dec 5, 2005 Gynazole 1, to 18 countries in south-eastern Europe. Financial details were not disclosed, but Richter will pay an upfront fee and commissions on sales. ... Pay-Per-View - Economist Intelligence Unit - Business... - Factiva, from Dow Jones |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |